These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24504679)

  • 1. Letter regarding "Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis" by Guo et al.
    Wang P; Sun L; Yu L; Wang H
    Tumour Biol; 2014 Jul; 35(7):6175. PubMed ID: 24504679
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis.
    Guo S; Bai R; Zhao W; Wang Y; Zhao Z; Feng W
    Tumour Biol; 2014 Jan; 35(1):469-73. PubMed ID: 23959472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter regarding Wen X.Y. et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis".
    Guo HB; Xiao T
    Tumour Biol; 2014 May; 35(5):5053. PubMed ID: 24449508
    [No Abstract]   [Full Text] [Related]  

  • 4. The prognostic value of elevated ezrin in patients with osteosarcoma.
    Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
    Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on Xu XW et al.: Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
    He S; Xiao Z; Chen L; Xiong S
    Tumour Biol; 2014 Jul; 35(7):6193-4. PubMed ID: 24852425
    [No Abstract]   [Full Text] [Related]  

  • 6. Questions about XY Wen et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis".
    Liu F; Zhang Q
    Tumour Biol; 2015 Feb; 36(2):557-8. PubMed ID: 25663465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on Lun et al. entitled "The prognostic value of elevated ezrin in patients with osteosarcoma".
    Li Z; Li Y
    Tumour Biol; 2014 May; 35(5):5051. PubMed ID: 24390666
    [No Abstract]   [Full Text] [Related]  

  • 8. Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.
    Wen X; Liu H; Yu K; Liu Y
    Tumour Biol; 2014 Jan; 35(1):845-8. PubMed ID: 24037915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
    Yu XW; Wu TY; Yi X; Ren WP; Zhou ZB; Sun YQ; Zhang CQ
    Tumour Biol; 2014 Jan; 35(1):155-60. PubMed ID: 23907576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of adenomatous polyposis coli gene expression in osteosarcoma of the extremities.
    Guimarães AP; Rocha RM; da Cunha IW; Guimarães GC; Carvalho AL; de Camargo B; Lopes A; Squire JA; Soares FA
    Eur J Cancer; 2010 Dec; 46(18):3307-15. PubMed ID: 20594821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NPRL2 is an independent prognostic factor of osteosarcoma.
    Gao Y; Wang J; Fan G
    Cancer Biomark; 2012-2013; 12(1):31-6. PubMed ID: 23321467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors in patients with osteosarcoma].
    Ying M; Zhang W; Liu Z
    Zhonghua Wai Ke Za Zhi; 1995 Feb; 33(2):93-6. PubMed ID: 7656713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of RB1 tumour suppressor gene alterations in the clinical outcome of human osteosarcoma: a meta-analysis.
    Ren W; Gu G
    Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26503016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of microRNAs in osteosarcoma: A meta-analysis.
    Kim YH; Goh TS; Lee CS; Oh SO; Kim JI; Jeung SH; Pak K
    Oncotarget; 2017 Jan; 8(5):8726-8737. PubMed ID: 28060730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma.
    Smida J; Baumhoer D; Rosemann M; Walch A; Bielack S; Poremba C; Remberger K; Korsching E; Scheurlen W; Dierkes C; Burdach S; Jundt G; Atkinson MJ; Nathrath M
    Clin Cancer Res; 2010 Aug; 16(16):4256-67. PubMed ID: 20610556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter regarding Wang et al. entitled "Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systematic review and meta-analysis".
    Bilbao-Aldaiturriaga N; Martin-Guerrero I; Garcia-Orad A
    Tumour Biol; 2014 Jul; 35(7):6179. PubMed ID: 24682904
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter regarding Li JS et al. entitled "ERCC polymorphisms and prognosis of patients with osteosarcoma".
    Jian Y; Tian X; Li B; Zhou Z; Wu X
    Tumour Biol; 2015 May; 36(5):3195-6. PubMed ID: 25824708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
    Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
    Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments on Li H et al. "A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma".
    Zhang Q; Li J; Liu F; Li Z
    Tumour Biol; 2015 Jan; 36(1):5-6. PubMed ID: 25416443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter regarding Chen et al. entitled "a systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma".
    Liu LH; Li H; Xiao T
    Tumour Biol; 2014 Sep; 35(9):8535. PubMed ID: 25168371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.